Moleculin Biotech, Inc.
NASDAQ:MBRX
1.77 (USD) • At close January 2, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.127 | 0.222 | 0.26 | 0.285 | 0.185 | 0.068 | 0.018 | 0.006 | 0 |
| Gross Profit
| -0.127 | -0.222 | -0.26 | -0.285 | -0.185 | -0.068 | -0.018 | -0.006 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 19.487 | 18.968 | 14.418 | 12.757 | 11.013 | 9.728 | 4.545 | 1.496 | 0.26 |
| General & Administrative Expenses
| 10.017 | 11.672 | 8.386 | 6.785 | 6.312 | 5.297 | 4.09 | 2.381 | 1.147 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.669 |
| SG&A
| 10.017 | 11.672 | 8.386 | 6.785 | 6.312 | 5.297 | 4.09 | 2.381 | 0.478 |
| Other Expenses
| 0.127 | 0.04 | 0.164 | 0.2 | 0.199 | -0.04 | 0.018 | 0.006 | 0 |
| Operating Expenses
| 29.631 | 30.64 | 22.968 | 19.742 | 17.524 | 15.025 | 8.653 | 3.883 | 0.738 |
| Operating Income
| -29.631 | -30.64 | -22.968 | -19.742 | -17.524 | -15.025 | -8.653 | -3.883 | -0.738 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -0.138 | 1.615 | 7.074 | 2.387 | 4.09 | 3.149 | -1.152 | -0.043 | -0.01 |
| Income Before Tax
| -29.769 | -29.025 | -15.894 | -17.355 | -13.434 | -11.876 | -9.805 | -3.926 | -0.748 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -1.615 | -7.034 | -2.359 | -0.229 | 3.145 | 1.152 | 0 | -1.772 |
| Net Income
| -29.769 | -27.41 | -8.86 | -14.996 | -13.205 | -11.876 | -9.805 | -3.926 | -0.748 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -15.07 | -14.37 | -4.94 | -22.85 | -29.18 | -41.26 | -47.52 | -35.96 | -11.88 |
| EPS Diluted
| -15.07 | -14.37 | -4.94 | -22.85 | -29.18 | -41.26 | -47.52 | -35.96 | -11.83 |
| EBITDA
| -29.504 | -30.51 | -22.804 | -19.542 | -13.249 | -14.957 | -8.635 | -3.877 | 0 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |